Evidence map›Paper›PMID 32610153›Full record

ArticleInternational journal of cardiology2020

COVID-19 trials in Italy: A call for simplicity, top standards and global pooling.

Aldo P Maggioni, Felicita Andreotti, Cristina Gervasoni, Giuseppe Di Pasquale

Abstract read
In one paragraph

Article in International journal of cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aldo P MaggioniANMCO Research Center, Florence, Italy. Electronic address: maggioni@anmco.it.
Felicita AndreottiPhysician Scientist, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Cristina GervasoniDepartment of Infectious Diseases Physician, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Giuseppe Di PasqualeLocal Health Authority, Bologna, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The novel coronavirus disease, affecting ~9 million people in the past five months and causing >460,000 deaths worldwide, is completely new to mankind. More than 2,000 research projects registered at ClinTrials.gov are aiming at finding effective treatments for rapid transfer to clinical practice. Unfortunately, just few studies have a sufficiently valid design to provide reliable information for clinical practice.

Indexed as

Clinical Trials as TopicCoronavirus InfectionsPandemicsPneumonia, ViralAntiviral AgentsBetacoronavirusCOVID-19COVID-19 Drug TreatmentDrug RepositioningHumansItalyResearchResearch DesignSARS-CoV-2Therapies, InvestigationalAntiviral Agents

Identifiers

PMID32610153
PMCPMC7321654

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.